PCSK9 and Hypocholesterolemia: The significance of PCSK9 for LDL cholesterol homeostasis is demonstrated with gain- and loss-of-function mutations in PCSK9, which results in hyper- or hypocholesterolemia in individuals, respectively, with significant effects on atherosclerotic cardiovascular disease and further advanced incidence [12,35,43].